Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
评估Amneal制药：来自4位金融分析师的见解
4 analysts have expressed a variety of opinions on Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有4位分析师对Amneal Pharmicals（纳斯达克股票代码：AMRX）表达了各种观点，从看涨到看跌，提出了各种各样的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $7.81, along with a high estimate of $9.00 and a low estimate of $6.25. Marking an increase of 26.17%, the current average surpasses the previous average price target of $6.19.
分析师提供了更深入的见解，确定了12个月的目标股价，平均目标价为7.81美元，最高估计为9.00美元，低估值为6.25美元。当前的平均价格上涨了26.17％，超过了之前的平均目标股价6.19美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
The analysis of recent analyst actions sheds...
对分析师最近行...
登录免费看全文
登录/注册